In outlining the changes to its manufacturing network, Pfizer also summarized how its transformed manufacturing network will
look. Pfizer's solid-dosage network will include plants in Freiburg, Germany; Amboise, France; Vega Baja and Barceloneta,
Puerto Rico; Ascoli, Italy; Newbridge, Ireland; and Illertissen, Germany. Its aseptic-manufacturing network will consist of
plants in Puurs, Belgium; Perth, Australia; Catania, Italy; and Kalamazoo, Michigan. Its biotechnology-manufacturing network
will consist of sites in Grange Castle, Ireland; Strangnas, Sweden; Algete, Spain; Havant, United Kingdom; Andover, Massachusetts;
and Sanford, North Carolina. The consumer healthcare network will include plants in Guayama, Puerto Rico; Montreal, Canada;
Albany, Georgia; Aprilia, Italy; Hsinchu, Taiwan; and Suzhou, Jiangsu, China.
Pfizer added to its manufacturing network in February 2011, when it acquired the specialty pharmaceutical company King Pharmaceuticals.
As of December 2010, King Pharmaceuticals had manufacturing facilities in Bristol, Tennessee; Rochester, Michigan; Middleton,
Wisconsin; and St. Petersburg, Florida, as well as an auto-injector manufacturing facility in St. Louis, according to King
Pharmaceuticals' 2010 SEC annual filing.
Pfizer is further expanding its manufacturing position in emerging markets, principally through alliances. In China, Pfizer
signed a memorandum of understanding (MOU) with Zhejiang Hisun Pharmaceutical in July 2011 for a possible joint venture, which
will include manufacturing cooperation, local and global sales and marketing infrastructure, and R&D of off-patent medicines.
In April 2011, Pfizer signed an MOU with Shanghai Pharmaceutical for a potential partnership for the registration and commercialization
of innovative Pfizer products in China. The companies also are examining cooperation in distribution, commercialization, R&D,
manufacturing, and equity investment. In South America, Pfizer acquired a 40% stake in Laboratório Teuto Brasileiro a generic-drug
company in Brazil in November 2010.
|
